We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+9.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
Cap. Flow
+$122M
Cap. Flow %
103.01%
Top 10 Hldgs %
7.37%
Holding
380
New
380
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.09%
2 Industrials 15.8%
3 Technology 14.93%
4 Healthcare 10.46%
5 Communication Services 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPVG icon
376
TriplePoint Venture Growth BDC
TPVG
$182M
$84.2K 0.07%
+11,404
New +$83.9K
NNOX icon
377
Nano X Imaging
NNOX
$61.7M
$80.2K 0.07%
+11,139
New +$71.3K
TK icon
378
Teekay
TK
$974M
$75.3K 0.06%
+10,871
New +$83.8K
WOLF icon
379
Wolfspeed
WOLF
$1.24B
$71.7K 0.06%
+10,762
New +$110K
CFFN icon
380
Capitol Federal Financial
CFFN
$1.07B
$69.9K 0.06%
+11,833
New +$75.4K

Similar funds

PharVision Advisers's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for PharVision Advisers, which disclosed 380 positions worth $118M. Its ten largest holdings account for 7.4% of the portfolio.

Its largest position is Booz Allen Hamilton: 6,467 shares worth $832K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, followed by Industrials and Technology.

  • PharVision Advisers's largest Q4 2024 buy was Booz Allen Hamilton: 6,467 shares worth $832K.
  • PharVision Advisers's ten largest holdings make up 7.4% of its $118M portfolio in Q4 2024.
  • PharVision Advisers disclosed 380 positions in Q4 2024, its first 13F filing on record.

Based on PharVision Advisers's 13F filing for Q4 2024, filed 18 Feb 2025.